The law signals major improvements in health care affordability for people with CF.
Site Search
Showing 31 - 33 of 33 results
News
|
Aug. 23, 2022
|
3 min read
CEO pledge is part of the Foundation’s ongoing commitment to strengthen the organization and better serve all people with CF
News
|
Sept. 1, 2022
|
3 min read
Orkambi® is now approved for use in children with cystic fibrosis ages 1-2 years who have two F508del mutations. This is the only modulator available to very young children with these mutations.
News
|
Sept. 2, 2022
|
3 min read